Pharmicell Co

Pharmicell Co FCF Margin

The Free Cash Flow Margin of Pharmicell Co (005690.KS) as of Nov 5, 2026 is 29.43 %. In the previous year, Free Cash Flow Margin was -1.30 % — a change of -2,371.85% (higher).

FCF Margin

29.43 %

YoY

-2,371.85%

Last updated:

Free Cash Flow Margin of Pharmicell Co is 2025 29.43 % . Free Cash Flow Margin of Pharmicell Co was 2024 -1.30 % . It decreases by -2,371.85% higher compared to the previous year.

The Pharmicell Co FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-4.49 KRW
Jan 1, 2019
-5.35 KRW
Jan 1, 2020
21.81 KRW
Jan 1, 2021
-18.42 KRW
Jan 1, 2022
-18.35 KRW
Jan 1, 2023
10.30 KRW
Jan 1, 2024
-1.30 KRW
Jan 1, 2025
29.43 KRW
The Pharmicell Co FCF Margin history
YEARFCF MarginYoY
29.43 %-2,371.85%
-1.30 %-112.57%
10.30 %-156.15%
-18.35 %-0.37%
-18.42 %-184.43%
21.81 %-507.75%
-5.35 %+19.21%
-4.49 %-81.99%
-24.92 %+142.43%
-10.28 %-67.46%
-31.60 %-29.75%
-44.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pharmicell Co Stock analysis

What does Pharmicell Co do? Pharmicell Co., Ltd. develops stem cell-based pharmaceuticals and technologies, focusing on stem cell therapeutic drugs and stem cell-based cosmetics. The company provides stem cell storage services and supplies mesenchymal stem cells (MSCs) for research purposes. It also operates a fashion business under the brand names Religion and Day, offering women’s and men’s apparel. The company merged with its wholly owned subsidiary on March 31, 2013, which was primarily engaged in medicine manufacturing and sales. Pharmicell generates revenue through its biopharmaceutical division, selling stem cell therapeutic drugs and cosmetics, as well as stem cell storage services and MSCs for research. The fashion business contributes through the sale of apparel under the Religion and Day brands. The primary buyers for pharmaceutical products include healthcare providers and research institutions, while the fashion segment targets consumers purchasing women’s and men’s clothing. The company’s segments are biopharmaceuticals, stem cell services, and fashion apparel. The biopharmaceutical business develops and manufactures stem cell-based drugs and cosmetics, with MSCs used in research areas. The fashion segment operates under the brand names Religion and Day, providing women’s and men’s apparel. The company’s revenue streams are derived from the sale of therapeutic drugs, cosmetics, stem cell storage, MSCs for research, and apparel sales. The merged subsidiary’s medicine manufacturing and sales activity complements the core biopharmaceutical operations. Pharmicell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmicell Co stock

Free Cash Flow Margin of Pharmicell Co is 29.43 % in 2025.

Free Cash Flow Margin of Pharmicell Co changed from -1.30 % to 29.43 %, representing a -2,371.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Pharmicell Co since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Pharmicell Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Pharmicell Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Pharmicell Co